Tagged: myomo

July 17, 2018 @ 3:41 pm By JD Alois  |  

Tripoint Global, a boutique investment bank based in Manhattan, and its online capital formation platform Banq – have been leaders in the Reg A+ crowdfunding space since the beginning. When the  rules were quite new, Mark Elenowitz, CEO of Tripoint, was quick to recognize the potential… Read More

December 28, 2017 @ 12:00 pm By JD Alois  |  

Darren Marble is CEO and founder of CrowdfundX – a firm that provides a modern spin on financial marketing for the new world of Fintech and online capital formation. Early on, Marble recognized the potential of Reg A+ crowdfunding in the US, as created by Title… Read More

August 13, 2017 @ 12:21 pm By JD Alois  |  

Via Folio is out with a statement on their services that help non-traditional issuers manage both assets and investors. Via Folio provides a vital bridge between issuers in newer securities like Regulation A+, as created by the JOBS Act. Reg A+ has seen growing utilization… Read More

June 22, 2017 @ 3:05 pm By JD Alois  |  

Last week there were two companies that raised money crowdfunding under Reg A+ and soon followed by trading on a public exchange. Myomo (NYSE:MYO), raised capital on Banq, and then listed on NYSE MKT. The shares have since traded to a high of about $23 /… Read More

June 19, 2017 @ 4:08 pm By JD Alois  |  

It has been one week since Myomo (NYSE:MYO) became the first Reg A+ issuer to successfully crowdfund and then list on NYSE MKT.  But since listing on the public exchange, Myomo has moved in the right direction.  The shares have rocketed from an issue price of… Read More

June 11, 2017 @ 3:54 pm By JD Alois  |  

Next week two smaller companies intend on listing their shares on a public exchange. What is interesting about this fact is that each of these companies used Regulation A or Reg A+ to facilitate this “mini-IPO” type offer. Created by Title IV of the JOBS… Read More

June 9, 2017 @ 3:28 pm By JD Alois  |  

Myomo, a medical robotics company that has developed powered brace to support a weak arm, will become the first Regulation A (Reg A+) issuer to immediately go from crowdfunding to actively trading on an exchange. Myomo will begin trading on the New York Stock Exchange… Read More

June 2, 2017 @ 6:15 pm By JD Alois  |  

We last wrote about Myomo, a commercial stage medical robots company (kind of like the Bionic Man), in March. Myomo was in the process of using Reg A+ to raise growth capital. Under the exemption, Myomo was seeking $15 million using Banq, a crowdfunding platform… Read More

March 15, 2017 @ 1:05 pm By JD Alois  |  

Reg A+, a securities exemption that was improved under the JOBS Act, has been touted as the solution to the dearth of IPOs in the US. But issuers are still working to figure out the best avenue to raise capital and then publicly trade shares…. Read More

November 22, 2016 @ 6:32 pm By JD Alois  |  

There has been a lot of buzz within the investment community regarding the updated exemption created under Title IV of the JOBS Act.  Regulation A+, or just Reg A+, was crafted by the SEC and Congress to allow issuers to raise up to $50 million… Read More

November 18, 2016 @ 11:10 am By JD Alois  |  

Myomo, a medical robotics company whose products enable users to overcome upper extremity paralysis, has filed a Form 1-A with the SEC indicating its intent to raise money under Reg A+, a crowdfunding exemption that allows issuers to seek up to $50 million in capital…. Read More